Gene Siegal: h-index, Total Citations, and Citation Map
Gene Siegal's h-index is 79 (308 i10-index, 24,695+ total citations across 641+ publications) according to Google Scholar as of June 2026. Gene Siegal is affiliated with Department of Pathology, University of Alabama at Birmingham.
Gene Siegal is a researcher affiliated with Department of Pathology, University of Alabama at Birmingham, specializing in Pathology, Bone, Cancer Pathology. Their work has been cited 24,695 times. This profile visualizes their global influence, spanning a global audience.
Gene Siegal's Citation Metrics
Bibliometric impact based on 641 indexed publications.
- H-Index
- 79
- i10-Index
- 308
- Total Citations
- 24,695
- Citing Countries
- 0
As of June 2026.
Gene Siegal has an h-index of 79 and 24,695 total citations across 641 publications, with research cited by institutions in 0 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Gene Siegal's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
We've mapped 5,000 of 24,695 citations for Gene Siegal
We've shown the most-cited 5,000. Unlock the full crawl (24,665 more citations) to see every institution citing this scholar.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival—a report from the Children's Oncology Group
2008930
Top Citing Countries
Top Citing Institutions
No institution data available.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
About Gene Siegal's research
Gene Siegal is a researcher in Pathology, Bone and Cancer Pathology at Department of Pathology, University of Alabama at Birmingham. Their work has been cited 24,695 times across 641 publications (h-index 79), according to Google Scholar.
Their most-cited work, “Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival—a report from the Children's Oncology Group” (2008), has accumulated 930 citations. Other influential works include “Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate” (2005) with 892 citations and “Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane” (1981) with 822 citations.
